Company Filing History:
Years Active: 2001
Title: Ian C Gray - Innovator in Cancer Diagnosis
Introduction
Ian C Gray is a notable inventor based in Peterborough, GB. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of cancer susceptibility. His innovative approach has the potential to impact patient care and treatment options.
Latest Patents
Ian C Gray holds a patent titled "Diagnosis of susceptibility to cancer and treatment thereof." This patent outlines a method for determining a patient's susceptibility to cancer. The process involves obtaining a sample containing nucleic acid from the patient and contacting it with a nucleic acid that selectively hybridizes to a specific region of human chromosome 10. This region is defined by the markers D10S541 and D10S215. The patent emphasizes that the nucleic acid used should not be any of the specified YACs, BACs, PACs, or ESTs. Ideally, the nucleic acid is a prostate tumor suppressor gene. Ian's work in this area showcases his commitment to advancing cancer diagnostics.
Career Highlights
Ian C Gray is associated with Imperial Cancer Research Technology, Ltd., where he applies his expertise in cancer research. His career is marked by a focus on innovative solutions that address critical health challenges. His contributions have been recognized within the scientific community, and he continues to work towards improving cancer diagnosis and treatment.
Collaborations
Ian has collaborated with notable colleagues, including Nigel Kay Spurr and Lorna M Stewart. These partnerships have fostered a collaborative environment that enhances research and innovation in cancer diagnostics.
Conclusion
Ian C Gray is a distinguished inventor whose work in cancer diagnosis has the potential to transform patient care. His innovative methods and collaborations reflect his dedication to advancing medical science.